McCartan is a dynamic pricing evangelist who has helped thousands of hotels, owners, and brands generate more revenue and improve profitability via the adoption of pricing automation and AI. In his hotel and travel technology career spanning over 20 years, he has held executive-level roles in large and well-known companies as well as early-stage start-ups.
McCartan is a recognized and sought-after speaker in the hotel technology space and is widely seen as an influencer in global hotel revenue management. In this role, McCartan represents IDeaS as a thought leader and speaker at industry events while leading the EMEA sales organization in current and new markets.
Vineeth is a seasoned AI leader with a proven track record of driving transformational change and delivering measurable business value through AI and Advanced Analytics. He has in his career spearheaded delivered multiple Gen AI applications across different banking business units, also responsible for developing scalable AI infrastructures, and ensuring ethical and regulatory compliance of Gen AI solutions.
Renowned for fostering innovation, enabling AI adoption, and aligning advanced technologies with strategic business goals to deliver impactful results.
Dr. Dehlinger-Kremer brings over 30 years of experience in the research industry, including 30 years with a particular focus on global regulatory affairs, medical affairs, and pediatric leadership. At ICON’s Center for Pediatric Clinical Development, she supports pediatric developments and advances in pediatric research. Additionally, as Co-Chair of ICON’s Maternal-Fetal Medicine Unit, Dr. Dehlinger-Kremer contributes to the search for innovative solutions in maternal-fetal health.
Prior to joining ICON, Dr. Dehlinger-Kremer served in several executive leadership roles at global CROs, and has experience in global drug development in more than 40 countries. Her vision and leadership extend to service with a number of professional organizations – she is an observer member of the Coordinating Group of Enpr-EMA at the European Medicines Agency, chair of the Pediatric Working Group and also President of the European CRO Federation (EUCROF), serves as chair of the European Forum for Good Clinical Practice (EFGCP) Children’s Medicines Working Party and Board Member of the association, and is active in the International Children’s Advisory Network (iCAN). She is an member of the ACT EU MSP Ad Hoc Advisory Group representatives.
In 2015, Dr. Dehlinger-Kremer was named one of PharmaVOICE’s 100 Most Inspiring People in Life Sciences.
Dr. Dehlinger-Kremer earned a Doctorate in Sciences from the J. W. Goethe University in Francfort on the Main, Germany; a Diploma of Advanced Study in Neurophysiology from the University Louis-Pasteur, Strasbourg, France; and a Master of Sciences degree from University Moulin de la Housse in Reims, France.
Diligent, results-focused professional with 10+ years’ experience in clinical data management, providing essential leadership to guide the efficient validation, entry, and programming to ensure data integrity and completeness. To ensure ICH GCP regulations and SOPs are adhered for all the CDM activities. Adapt at allocating tasks, aligning efforts, and supervising performance to support achievement of company goals while driving adherence to operating procedures and corporate guidelines. Articulate and engaging with excellent interpersonal skills; readily establish collaborative partnerships with colleagues, vendors, and managers. Capable of efficiently managing offshore data management teams. Therapeutical experience in Oncology, CNS, Hemophilia, Gastroenterology, Anti-Infectives.
An experienced digital strategist in clinical R&D space with end-to-end knowledge on dataflow, business processes, systems and technologies. He currently plays a role of IT Business Partner in Otsuka for multiple business functions: Clinical Data Management, Pharmacovigilance, Statistical Programming, Biostatistics and Clinical Operations. He speaks the language of both business and IT and is responsible for large platform transformations, ideations, digital vision and roadmap. He manages strategic R&D partnerships with product vendors in the areas of clinical data review, SCE, clinical analytics and submission platforms. He also works with the leadership of Otsuka affiliate pharma companies: Taiho Oncology, Otsuka Japan etc. Previous to Otsuka, he has provided his consulting services as clinical R&D solution architect to big pharma companies: GSK Consumer Health, BMS, Amgen and Novartis.
How to simplify the data management process and activities. Highly motivated, astute, and results-driven self-starter with exceptional organizational, analytical, and clinical data management skills. B.S. and 15 + years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, Oncology expertise, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward. Diligent, detail-centric, and trustworthy. A strategic and critical-thinking collaborator and avid problem solver. Known for taking on the most challenging tasks and the ability to fast break into uncharted areas.
Currently leading data management Inspirna(formerly known as Rgenix) and supporting CMO and the rest of the team.
Dedicated security professional with a diverse history of working in healthcare, education, nonprofit and SaaS environments. Skilled in Microsoft 365 architecture, IAM/IGA and business process automation. Current MSc candidate in Computing Security at Rochester Institute of Technology.
